OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
BUB$0.1060

Bubs Australia Ltd

Food ProcessingVerified

Bubs Australia maintains a strong liquidity position with a current ratio of 3.65, indicating the company can cover its short-term liabilities more than three times over. The company's price-to-book ratio of 2.1 and price-to-tangible-book ratio of 2.1 suggest that the market values the company at a premium to its book value, reflecting intangible assets and brand equity. The company's market capitalization of 89.4 million AUD is supported by a price-to-earnings ratio of 16.13, which is in line with the industry's valuation norms. In terms of profitability, Bubs Australia reports a return on equity of 13.05% and a return on assets of 9.7%, which are strong indicators of efficient use of equity and assets. The company's operating income of 4.5 million AUD and net income of 5.5 million AUD reflect a healthy margin, although the gross profit of 49.06 million AUD suggests that the company's cost of goods sold is a significant portion of its revenue. The company's revenue is primarily concentrated in Australia, with exports to China, Southeast Asia, the Middle East, and the United States. While the company has a diversified geographic presence, the majority of its revenue is still derived from its domestic market, which could expose it to regional economic fluctuations. The company's product portfolio includes infant formula, organic baby food, and adult nutritional products, with a focus on premium and organic offerings. Looking ahead, Bubs Australia is expected to maintain a stable growth trajectory, supported by its strong brand presence and product diversification. The company's free cash flow of 6.44 million AUD and operating cash flow of 6.13 million AUD indicate a solid cash generation capability, which can be reinvested or used for shareholder returns. The company's capital expenditure of -83,010 AUD suggests that it is not currently investing heavily in new projects, which may indicate a focus on maintaining existing operations. The company's risk profile is characterized by a medium liquidity risk and a low dilution risk. The debt-to-equity ratio of 0.02 indicates that the company is not heavily leveraged, which reduces financial risk. However, the company's net cash position is negative after subtracting total debt, which could be a concern if cash flow were to decline. The company's low dilution risk is supported by the absence of near-term dilution pressures, as indicated by the low dilution potential and the lack of recent equity issuances. Recent events, including analyst estimates and price targets, suggest a generally positive outlook for the company. The mean price target of 0.16 AUD and the median price target of 0.16 AUD indicate that analysts expect the stock to appreciate from its current market price of 0.10 AUD. The mean recommendation of 2.00 (1=strong buy, 5=strong sell) and the three "buy" ratings suggest that the company is viewed favorably by the analyst community.

30-day price · BUB-0.01 (-10.0%)
Low$0.10High$0.11Close$0.10As of17 May, 00:00 UTC
Profile
CompanyBubs Australia Ltd
TickerBUB.AX
SectorConsumer Non-Cyclicals
BusinessFood & Beverages
Industry groupFood & Beverages
IndustryFood Processing
AI analysis

Business. Bubs Australia Limited produces and sells infant and adult chilled and powdered goat dairy products, including infant formula, organic baby food, and adult nutritional powders, primarily under the Bubs and Caprilac brands.

Classification. Bubs Australia is classified in the Consumer Non-Cyclicals economic sector, Food & Beverages business sector, and Food Processing industry with a confidence level of 0.92.

Bubs Australia maintains a strong liquidity position with a current ratio of 3.65, indicating the company can cover its short-term liabilities more than three times over. The company's price-to-book ratio of 2.1 and price-to-tangible-book ratio of 2.1 suggest that the market values the company at a premium to its book value, reflecting intangible assets and brand equity. The company's market capitalization of 89.4 million AUD is supported by a price-to-earnings ratio of 16.13, which is in line with the industry's valuation norms. In terms of profitability, Bubs Australia reports a return on equity of 13.05% and a return on assets of 9.7%, which are strong indicators of efficient use of equity and assets. The company's operating income of 4.5 million AUD and net income of 5.5 million AUD reflect a healthy margin, although the gross profit of 49.06 million AUD suggests that the company's cost of goods sold is a significant portion of its revenue. The company's revenue is primarily concentrated in Australia, with exports to China, Southeast Asia, the Middle East, and the United States. While the company has a diversified geographic presence, the majority of its revenue is still derived from its domestic market, which could expose it to regional economic fluctuations. The company's product portfolio includes infant formula, organic baby food, and adult nutritional products, with a focus on premium and organic offerings. Looking ahead, Bubs Australia is expected to maintain a stable growth trajectory, supported by its strong brand presence and product diversification. The company's free cash flow of 6.44 million AUD and operating cash flow of 6.13 million AUD indicate a solid cash generation capability, which can be reinvested or used for shareholder returns. The company's capital expenditure of -83,010 AUD suggests that it is not currently investing heavily in new projects, which may indicate a focus on maintaining existing operations. The company's risk profile is characterized by a medium liquidity risk and a low dilution risk. The debt-to-equity ratio of 0.02 indicates that the company is not heavily leveraged, which reduces financial risk. However, the company's net cash position is negative after subtracting total debt, which could be a concern if cash flow were to decline. The company's low dilution risk is supported by the absence of near-term dilution pressures, as indicated by the low dilution potential and the lack of recent equity issuances. Recent events, including analyst estimates and price targets, suggest a generally positive outlook for the company. The mean price target of 0.16 AUD and the median price target of 0.16 AUD indicate that analysts expect the stock to appreciate from its current market price of 0.10 AUD. The mean recommendation of 2.00 (1=strong buy, 5=strong sell) and the three "buy" ratings suggest that the company is viewed favorably by the analyst community.
Key takeaways
  • Bubs Australia has a strong liquidity position with a current ratio of 3.65.
  • The company's return on equity of 13.05% and return on assets of 9.7% indicate efficient use of equity and assets.
  • The company's revenue is primarily concentrated in Australia, with exports to several international markets.
  • Analysts have a generally positive outlook, with a mean price target of 0.16 AUD and three "buy" ratings.
  • The company's low debt-to-equity ratio of 0.02 suggests a conservative capital structure.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyAUD
Revenue$102.5M
Gross profit$49.1M
Operating income$4.5M
Net income$5.5M
R&D
SG&A
D&A
SBC
Operating cash flow$6.1M
CapEx-$83.0k
Free cash flow$6.4M
Total assets$57.2M
Total liabilities$14.7M
Total equity$42.5M
Cash & equivalents
Long-term debt$967.5k
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price$0.10
Market cap$89.4M
Enterprise value$90.4M
P/E16.1
Reported non-GAAP P/E
EV/Revenue0.9
EV/Op income20.0
EV/OCF14.7
P/B2.1
P/Tangible book2.1
Tangible book$42.5M
Net cash-$967.5k
Current ratio3.6
Debt/Equity0.0
ROA9.7%
ROE13.1%
Cash conversion1.1%
CapEx/Revenue-0.1%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Food Processing · cohort 6 companies
MetricBUBActivity
Op margin4.4%3.3% medp25 2.5% · p75 4.5%above median
Net margin5.4%3.0% medp25 1.5% · p75 6.7%above median
Gross margin47.8%24.0% medp25 20.2% · p75 35.3%top quartile
R&D / revenue0.8% medp25 0.5% · p75 2.3%
CapEx / revenue-0.1%5.2% medp25 4.8% · p75 5.7%bottom quartile
Debt / equity2.0%33.5% medp25 29.1% · p75 81.5%bottom quartile
Observations
IR observations
Mean price target0.16 AUD
Median price target0.16 AUD
High price target0.18 AUD
Low price target0.15 AUD
Mean recommendation2.00 (1=strong buy, 5=strong sell)
Strong-buy count0.00
Buy count3.00
Hold count0.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate0.00 AUD
Last actual EPS0.01 AUD
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 06:05 UTC#4060299b
Market quoteclose AUD 0.10 · shares 0.89B diluted
no public URL
2026-05-10 06:05 UTC#7a423f2e
Source: analysis-pipeline (hybrid)Generated: 2026-05-10 06:07 UTCJob: d6df33b9